GMS Ventures & Investments 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-12 9:11 pm Purchase |
2025-03-11 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS Ventures & Investments | 16,183,787 41.600% |
3,458,571 (+27.18%) |
Filing |
| 2025-01-22 4:17 pm Purchase |
2025-01-17 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS Ventures & Investments | 12,725,216 38.600% |
3,458,571 (+37.32%) |
Filing |
| 2024-03-20 5:24 pm Purchase |
2024-03-18 | 13D | Outlook Therapeutics, Inc. OTLK |
GMS Ventures & Investments | 9,266,645 37.000% |
9,266,645 (New Position) |
Filing |